Oct. 8, 2009 (China Knowledge) - U.K.-based pharmaceutical company GlaxoSmithKline has signed an agreement to set up a joint venture with Chinese vaccine maker Jiangsu Walvax Biotech Co, sources reported on Tuesday.
The joint venture will produce vaccines for children at a new facility to be built by GSK.
GSK will initially invest US$32 million for a 65% stake in the joint venture, while Walvax
.....